This web site is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

Pol-Theta Program

Artios Pharma Ltd.

Description: The Pol-Theta Program targets the pol-theta molecule which is thought to control DNA repair processes in certain tumours. Knocking out the target could remove a path relied on by the cancer cell, causing it to die.

Pol-Theta Program News

Additional information available to subscribers only:

  • Targets
  • Routes
  • Catalysts
  • Designations
  • Events

Request a Free Demo Subscriber Login Search for another drug